收费全文 | 3204234篇 |
免费 | 237299篇 |
国内免费 | 7126篇 |
耳鼻咽喉 | 43839篇 |
儿科学 | 104395篇 |
妇产科学 | 86938篇 |
基础医学 | 469933篇 |
口腔科学 | 89502篇 |
临床医学 | 299316篇 |
内科学 | 613806篇 |
皮肤病学 | 68628篇 |
神经病学 | 258193篇 |
特种医学 | 118298篇 |
外国民族医学 | 810篇 |
外科学 | 470411篇 |
综合类 | 69729篇 |
现状与发展 | 13篇 |
一般理论 | 1224篇 |
预防医学 | 261555篇 |
眼科学 | 74143篇 |
药学 | 238255篇 |
16篇 | |
中国医学 | 6826篇 |
肿瘤学 | 172829篇 |
2021年 | 25803篇 |
2019年 | 26710篇 |
2018年 | 37041篇 |
2017年 | 27935篇 |
2016年 | 30916篇 |
2015年 | 35077篇 |
2014年 | 49127篇 |
2013年 | 74967篇 |
2012年 | 102803篇 |
2011年 | 109547篇 |
2010年 | 64791篇 |
2009年 | 60568篇 |
2008年 | 101939篇 |
2007年 | 108403篇 |
2006年 | 109257篇 |
2005年 | 105784篇 |
2004年 | 101016篇 |
2003年 | 96901篇 |
2002年 | 93706篇 |
2001年 | 142440篇 |
2000年 | 146401篇 |
1999年 | 123256篇 |
1998年 | 36550篇 |
1997年 | 32163篇 |
1996年 | 32170篇 |
1995年 | 30427篇 |
1994年 | 28253篇 |
1993年 | 26575篇 |
1992年 | 96762篇 |
1991年 | 94937篇 |
1990年 | 92381篇 |
1989年 | 88559篇 |
1988年 | 81718篇 |
1987年 | 80151篇 |
1986年 | 75681篇 |
1985年 | 72542篇 |
1984年 | 54223篇 |
1983年 | 46342篇 |
1982年 | 27756篇 |
1979年 | 49984篇 |
1978年 | 35720篇 |
1977年 | 29573篇 |
1976年 | 28577篇 |
1975年 | 30253篇 |
1974年 | 36534篇 |
1973年 | 35208篇 |
1972年 | 32854篇 |
1971年 | 30979篇 |
1970年 | 28699篇 |
1969年 | 26906篇 |
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献Interstitial lung disease (ILD) represents a significant cause of morbidity and mortality in systemic sclerosis (SSc). The purpose of this study was to examine recirculating lymphocytes from SSc patients for potential biomarkers of interstitial lung disease (ILD). Peripheral blood mononuclear cells (PBMCs) were isolated from patients with SSc and healthy controls enrolled in the Vanderbilt University Myositis and Scleroderma Treatment Initiative Center cohort between 9/2017–6/2019. Clinical phenotyping was performed by chart abstraction. Immunophenotyping was performed using both mass cytometry and fluorescence cytometry combined with t-distributed stochastic neighbor embedding analysis and traditional biaxial gating. This study included 34 patients with SSc-ILD, 14 patients without SSc-ILD, and 25 healthy controls. CD21lo/neg cells are significantly increased in SSc-ILD but not in SSc without ILD (15.4 ± 13.3% vs. 5.8 ± 0.9%, p = 0.002) or healthy controls (5.0 ± 0.5%, p < 0.0001). While CD21lo/neg B cells can be identified from a single biaxial gate, tSNE analysis reveals that the biaxial gate is comprised of multiple distinct subsets, all of which are increased in SSc-ILD. CD21lo/neg cells in both healthy controls and SSc-ILD are predominantly tBET positive and do not have intracellular CD21. Immunohistochemistry staining demonstrated that CD21lo/neg B cells diffusely infiltrate the lung parenchyma of an SSc-ILD patient. Additional work is needed to validate this biomarker in larger cohorts and longitudinal studies and to understand the role of these cells in SSc-ILD.
相似文献